VistaGen Therapeutics, Inc. (VTGN) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -16.2M | -17.63M | -13.76M | -18.85M | -10.06M | -10.28M | -10.89M | -10.87M | -7.2M | -4.75M | -6.19M | -7.89M |
| Operating CF Margin % | -3483.87% | -5818.81% | -5332.95% | -7723.77% | 67080% | -4393.16% | -5948.63% | -12939.29% | -3647.8% | -1153.86% | -2226.47% | -4458.14% |
| Operating CF Growth % | -61% | -71.51% | -26.39% | -73.39% | -39.81% | -116.56% | -75.88% | -37.74% | 3.69% | 52.21% | 62.12% | 50.58% |
| Net Income | -16.27M | -18.9M | -19.42M | -15.1M | -13.63M | -14.09M | -12.96M | -10.73M | -9.52M | -6.35M | -6.59M | -6.9M |
| Depreciation & Amortization | 190K | 189K | 185K | 169K | 166K | 161K | 157K | 151K | 146.5K | 143K | 140.3K | 340K |
| Stock-Based Compensation | 889K | 1.1M | 1.1M | 916K | 963K | 1.08M | 1.11M | 1.16M | 522.5K | 507K | 583.7K | 569K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.05M | 0 |
| Other Non-Cash Items | -132K | -143K | -146K | -122K | -128K | -102K | -140K | -19K | 6K | 1.38M | -1.05M | 367.1K |
| Working Capital Changes | -873K | 126K | 4.52M | -4.71M | 2.57M | 2.67M | 946K | -1.43M | 1.65M | -424K | -325.9K | -1.69M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -243K | 294K | 3.2M | -2.42M | 0 | 1.98M | 1.2M | -455K | 1.92M | 268.7K | -450.3K | -1.21M |
| Cash from Investing | -99K | 104K | -94K | -788K | 527K | -422K | -7.79M | -5.47M | -28.7K | -32K | 0 | 0 |
| Capital Expenditures | -190K | 125K | -60K | -65K | -88K | 0 | 42K | -42K | -28.7K | -32K | 0 | 0 |
| CapEx % of Revenue | 40.86% | 41.25% | 23.26% | 26.64% | -586.67% | - | 22.95% | 50% | 14.55% | 7.78% | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 190K | -151K | 0 | 0 | 0 | 0 | -103K | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -283K | 2.11M | 27.65M | 1.49M | 1.95M | 1.17M | 0 | 88K | -167.8K | 93.73M | 34.18M | 875.6K |
| Debt Issued (Net) | -283K | -278K | -274K | 930K | 0 | 0 | 0 | 0 | 1K | 1K | -784.6K | -200.9K |
| Equity Issued (Net) | 0 | 2.39M | 27.93M | 558K | 1.95M | 1.06M | -88K | 88K | -168.8K | 93.73M | 34.96M | 1.08M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 113K | 88K | 0 | 0 | 3K | 3.7K | 0 |
| Net Change in Cash | -16.58M | -15.41M | 13.8M | -18.15M | -7.58M | -9.53M | -18.67M | -16.25M | -7.39M | 88.95M | 27.99M | -7.02M |
| Free Cash Flow | -16.32M | -17.57M | -13.82M | -18.91M | -10.15M | -10.28M | -10.84M | -10.91M | -7.23M | -4.78M | -6.19M | -7.89M |
| FCF Margin % | -3510.75% | -5799.01% | -5356.2% | -7750.41% | 67666.67% | -4393.16% | -5925.68% | -12989.29% | -3662.34% | -1161.64% | -2226.47% | -4458.14% |
| FCF Growth % | -60.84% | -70.92% | -27.43% | -73.32% | -40.47% | -115.11% | -75.2% | -38.27% | 3.3% | 51.95% | 62.18% | 51.12% |
| FCF per Share | -0.43 | -0.42 | -0.39 | -0.59 | -0.33 | -0.33 | -0.35 | -0.36 | -0.27 | -0.33 | -0.62 | -1.07 |
| FCF Conversion (FCF/Net Income) | 1.00x | 0.93x | 0.71x | 1.25x | 0.74x | 0.73x | 0.84x | 1.01x | 0.76x | 0.75x | 0.94x | 1.14x |
| Interest Paid | 0 | 0 | 13K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |